Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases
Description
Pathological processes of the URINARY TRACT in both males and females. MeSH
Hierarchy View
Subtype Terms (8)
Kidney Diseases
428 drugs (259 approved, 169 experimental)
Ureteral Diseases
40 drugs (29 approved, 11 experimental)
Urethral Diseases
17 drugs (14 approved, 3 experimental)
Urinary Bladder Diseases
51 drugs (32 approved, 19 experimental)
Urinary Tract Infections
192 drugs (109 approved, 83 experimental)
Urination Disorders
54 drugs (40 approved, 14 experimental)
Urolithiasis
29 drugs (22 approved, 7 experimental)
Urologic Neoplasms
33 drugs (24 approved, 9 experimental)
Approved Indicated Drugs (4)
Phase 4 Indicated Drugs (4)
Phase 2 Indicated Drugs (5)
Phase 1 Indicated Drugs (3)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
